RxDoctor Payments Data

Scott Hopkins, MD

Urology · Slc, UTNPI 1649310681

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,393 of the $4,242 with a category attached, or 80.0%. 21 manufacturers reported payments, led by Procept Biorobotics Corporation at 32.0% of the total. 2025 is the largest year on record at $2,213, more than ten times the $169 reported in 2019.

$4,242in general payments, 2019–2025

Across 145 payments — averaging $29.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Procept Biorobotics Corporation$1K
  • Boston Scientific$1K
  • AbbVie$710
  • Endo Pharmaceuticals Inc.$132
  • Astellas Pharma US Inc$115
  • Dornier Medtech America, Inc$101
  • plus $660 from 15 others

What the payments were for

  • Travel & lodging$84120%
  • Food & beverage$3,39380%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,242 in reported general payments places this provider in the 55th percentile of 96 urology providers in Utah.

See all urology providers in Utah

Medicare billing

Part B allowed, 2024
$160,180
Medicare patients
223
Services billed
5,182

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methenamine Hippurate78$8,861
Potassium Citrate ErPotassium Citrate30$5,364
Trospium Chloride44$4,760
Tamsulosin Hcl181$1,744
Oxybutynin Chloride ErOxybutynin Chloride76$1,123
Testosterone Cypionate32$1,112
Naproxen87$972
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst48$766
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim63$476
Doxycycline Hyclate12$356
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen69$312
Ciprofloxacin Hcl28$175
Finasteride12$113
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$90
Levofloxacin20$69

Paid to pharmacies, not to this prescriber.

Other urology in Slc

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →